Effect Of Ksharadi Lauham Along With Diet And Life Style Modification In Patient Having Dyslipidemia (Medoroga)
Phase 2
- Conditions
- Health Condition 1: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2024/03/063724
- Lead Sponsor
- All India Institute Of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient Fulfilling The Diagnostic Criteria Of Dyslipidemia
Serum Triglyceride 150-250 mg/dl Or
Serum Cholesterol 200-239 mg/dl Or
Serum LDL Cholesterol 130-159 mg/dl Or
Serum HDL Cholesterol Male Less than 40 mg/dl Female Less than 50 mg/dl
Exclusion Criteria
1 Patients With Uncontrolled Diabetes Mellitus (Hba1c More Than 9%)
2 Uncontrolled Hypothyroidism (TSH More Than 10 mIU/L)
3 Patients With Severe Cardiovascular Disease Like MI CAD Cardiac Failure Any Other Life Threatening Condition
4 History Of Hypersensitivity To Any Of The Trial Drugs Or Their Ingredients
5 Pregnancy And Lactating Women
6 Any Other Conditions /Medications Which Can Interfere With Interventions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 50% Reduction In Raise Abnormal Lipid Level <br/ ><br>1 Serum Cholesterol Reduction From 239 To 220 mg/dl <br/ ><br>2 Serum Triglyceride Reduction From 250 To 200 mg/dl <br/ ><br>3 Serum LDL Cholesterol Reduction From 159 To 145 mg/dl <br/ ><br> <br/ ><br>Timepoint: Day 0 And Day 45
- Secondary Outcome Measures
Name Time Method 1 Changes In The Signs And Symptoms Of Medoroga <br/ ><br>2 Overall Improvement In Quality Of Life <br/ ><br>3 Safety Assessment Of The Trial Drug <br/ ><br>Timepoint: Day 0 And Day 45